Company / Return on Equity (ROE)
Cencora Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
103.1%
FY2025
5-year range
103.1% / 383.0%
FY2021-FY2025
Trend
-55.9%
vs FY2024
Sector context
#1 of 147
Health Care
What the data says
Among 147 Health Care companies, Cencora is in the top 1% for return on equity (roe). Return on Equity (ROE) has declined for 3 consecutive years, from 383.0% in FY2021 to 103.1% in FY2025.
Based on SEC 10-K filings.
103.1% in FY2025. Ranks 1st among 147 companies in Health Care.
Declined from 295.0% to 103.1% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Top 1% in Health CareTop 1% of 147This company 103.1% Sector average -3.3%
▼
+3229.9% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 55.9% year-over-year.
- Currently 106.4pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 4.32 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 103.1% | -55.9% |
| FY2024 | 233.6% | -20.8% |
| FY2023 | 295.0% | - |
| FY2022 | - | - |
| FY2021 | 383.0% | - |
| FY2020 | - | - |
| FY2019 | 29.7% | -47.5% |
| FY2018 | 56.5% | +220.2% |
| FY2017 | 17.7% | -73.7% |
| FY2016 | 67.1% | +399.1% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026